Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern Myanmar

Jordi Landier, Warat Haohankhunnatham, Smita Das, Kamonchanok Konghahong, Peter Christensen, Jathee Raksuansak, Pase Phattharakokoedbun, Ladda Kajeechiwa, May Myo Thwin, Ihn Kyung Jang, Mallika Imwong, Jacher Wiladphaingern, Khin Maung Lwin, Clare Ling, Stephane Proux, Gonzalo J Domingo, Gilles Delmas, François H Nosten, Jordi Landier, Warat Haohankhunnatham, Smita Das, Kamonchanok Konghahong, Peter Christensen, Jathee Raksuansak, Pase Phattharakokoedbun, Ladda Kajeechiwa, May Myo Thwin, Ihn Kyung Jang, Mallika Imwong, Jacher Wiladphaingern, Khin Maung Lwin, Clare Ling, Stephane Proux, Gonzalo J Domingo, Gilles Delmas, François H Nosten

Abstract

In the Greater Mekong Subregion in Southeast Asia, malaria elimination strategies need to target all Plasmodium falciparum parasites, including those carried asymptomatically. More than 70% of asymptomatic carriers are not detected by current rapid diagnostic tests (RDTs) or microscopy. An HRP2-based ultrasensitive RDT (uRDT) developed to improve the detection of low-density infections was evaluated during prevalence surveys within a malaria elimination program in a low-transmission area of eastern Myanmar. Surveys were conducted to identify high-prevalence villages. Two-milliliter venous blood samples were collected from asymptomatic adult volunteers and transported to the laboratory. Plasmodium parasites were detected by RDT, uRDT, microscopy, ultrasensitive qPCR (uPCR), and multiplex enzyme-linked immunosorbent assay (ELISA). The sensitivity, specificity, and predictive positive and negative values of RDT and uRDT were calculated compared to uPCR and ELISA. Parasite and antigen concentrations detected by each test were defined using uPCR and ELISA, respectively. A total of 1,509 samples, including 208 P. falciparum-positive samples were analyzed with all tests. The sensitivity of the uRDT was twofold higher than that of RDT, 51.4% versus 25.2%, with minor specificity loss, 99.5% versus 99.9%, against the combined reference (uPCR plus ELISA). The geometric mean parasitemia detected by uRDT in P. falciparum monospecific infections was 3,019 parasites per ml (95% confidence interval [95% CI], 1,790 to 5,094; n = 79) compared to 11,352 parasites per ml (95% CI, 5,643 to 22,837; n = 38) by RDT. The sensitivities of uRDT and RDT dropped to 34.6% and 15.1%, respectively, for the matched tests performed in the field. The uRDT performed consistently better than RDT and microscopy at low parasitemias. It shows promising characteristics for the identification of high-prevalence communities and warrants further evaluation in mass screening and treatment interventions.

Keywords: Plasmodium falciparum; asymptomatic infection; low density parasitemia; low transmission setting; malaria; rapid tests; ultrasensitive RDT.

Copyright © 2018 Landier et al.

Figures

FIG 1
FIG 1
Flowchart of study participants and results. Species results obtained by the combination of Plasmodium DNA detection by uPCR and Plasmodium antigens by Quansys ELISA (reference C) are displayed.
FIG 2
FIG 2
Increased range of PfHRP2 detection in uRDT compared to RDT and corresponding increase in detection of lower parasitemias for rapid tests performed in the laboratory (A) or in the field (B). Parasitemia measured by uPCR and the corresponding PfHRP2 concentration by Quansys ELISA are presented for samples positive for P. falciparum only by uPCR (monospecific infection) and by type of detection method. Vertical lines indicate PfHRP2 concentrations of 100 and 2,000 pg/ml, while horizontal lines correspond to 1,000 and 100,000 parasites/ml (see the text). Mixed P. falciparum plus P. vivax uPCR-positive samples and Plasmodium DNA-positive samples with PfHRP2 are presented in Fig. S1 in the supplemental material.
FIG 3
FIG 3
Probability of a P. falciparum-positive test for uRDT compared to RDT according to the parasitemia in uPCR-positive single P. falciparum infections. (A) Lab test results (solid line) and 95% CI (shaded area); field test results (dashed line). (B) Field test results (solid line) and 95% CI (shaded area); lab test results (dashed line).
FIG 4
FIG 4
Readability of the uRDT in the laboratory. Agreement between readers, semiquantitative assessment of signal intensity, corresponding results according to reference C, and matching results of field uRDT testing.
FIG 5
FIG 5
Theoretical distribution of P. falciparum parasitemia among carriers in the Greater Mekong Subregion (reference data from Imwong et al. [3] shown by the gray bars) and the corresponding fraction of each class that would be detected by uRDT (Table 4, laboratory uRDT results shown by the black bars). If used in optimal conditions, uRDT is predicted to detect up to 56% of the carriers in the GMS setting.

References

    1. Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, Smithuis FM, Hlaing M, Tun KM, Van Der Pluijm RW, Tripura R, Miotto O, Menard D, Dhorda M, Day NPJ, White NJ, Dondorp AM. 2017. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study. Lancet Infect Dis 17:491–497. doi:10.1016/S1473-3099(17)30048-8.
    1. Rabinovich RN, Drakeley C, Djimde AA, Hall BF, Hay SI, Hemingway J, Kaslow DC, Noor A, Okumu F, Steketee R, Tanner M, Wells TNC, Whittaker MA, Winzeler EA, Wirth DF, Whitfield K, Alonso PL. 2017. malERA: an updated research agenda for malaria elimination and eradication. PLoS Med 14:1–17. doi:10.1371/journal.pmed.1002456.
    1. Imwong M, Stepniewska K, Tripura R, Peto TJ, Lwin KM, Vihokhern B, Wongsaen K, von Seidlein L, Dhorda M, Snounou G, Keereecharoen L, Singhasivanon P, Sirithiranont P, Chalk J, Nguon C, Day NPJ, Nosten F, Dondorp A, White NJ. 2016. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis 213:1322–1329. doi:10.1093/infdis/jiv596.
    1. Parker DM, Carrara VI, Pukrittayakamee S, McGready R, Nosten FH. 2015. Malaria ecology along the Thailand-Myanmar border. Malar J 14:388. doi:10.1186/s12936-015-0921-y.
    1. Smithuis FM, Kyaw M, Phe U, van der Broek I, Katterman N, Rogers C, Almeida P, Kager PA, Stepniewska K, Lubell Y, Simpson JA, White NJ. 2013. The effect of insecticide-treated bed nets on the incidence and prevalence of malaria in children in an area of unstable seasonal transmission in western Myanmar. Malar J 12:363. doi:10.1186/1475-2875-12-363.
    1. Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, Song J, Yeung S, Dondorp AM, Day NP, White NJ, White LJ. 2012. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One 7:e37166. doi:10.1371/journal.pone.0037166.
    1. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, Imwong M, Miotto O, Patumrat K, Duanguppama J, Cerqueira D, Malleret B, Renia L, Nosten S, Von Seidlein L, Ling C, Proux S, Corbel V, Simpson JA, Dondorp AM, White NJ, Nosten FH. 2017. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Res 2:81. doi:10.12688/wellcomeopenres.12240.1.
    1. Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. 2017. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J 284:2569–2578. doi:10.1111/febs.14127.
    1. Landier J, Parker DM, Thu AM, Carrara VI, Lwin KM, Bonnington CA, Pukrittayakamee S, Delmas G, Nosten FH. 2016. The role of early detection and treatment in malaria elimination. Malar J 15:363. doi:10.1186/s12936-016-1399-y.
    1. Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, Stone W, Hellewell J, Lanke K, Bastiaens GJH, Bradley J, Nébié I, Ngoi JM, Oriango R, Mkabili D, Nyaurah M, Midega J, Wirth DF, Marsh K, Churcher TS, Bejon P, Sirima SB, Drakeley C, Bousema T. 2017. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun 8:1133. doi:10.1038/s41467-017-01270-4.
    1. Tadesse FG, Slater HC, Chali W, Teelen K, Lanke K, Belachew M, Menberu T, Shumie G, Shitaye G, Okell LC, Graumans W, van Gemert G-J, Kedir S, Tesfaye A, Belachew F, Abebe W, Mamo H, Sauerwein R, Balcha T, Aseffa A, Yewhalaw D, Gadisa E, Drakeley C, Bousema T. 2018. The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia. Clin Infect Dis 66:1883–1891. doi:10.1093/cid/cix1123.
    1. Nguyen TN, von Seidlein L, Nguyen TV, Truong PN, Hung SD, Pham HT, Nguyen TU, Le TD, Dao VH, Mukaka M, Day NP, White NJ, Dondorp AM, Thwaites GE, Hien TT. 2018. The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study. Lancet Infect Dis 18:565–572. doi:10.1016/S1473-3099(18)30046-X.
    1. Tadesse FG, Van Den Hoogen L, Lanke K, Schildkraut J, Tetteh K, Aseffa A, Mamo H, Sauerwein R, Felger I, Drakeley C, Gadissa E, Bousema T. 2017. The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia. Malar J 16:99. doi:10.1186/s12936-017-1749-4.
    1. Cook J, Xu W, Msellem M, Vonk M, Bergström B, Gosling R, Al-Mafazy A-W, McElroy P, Molteni F, Abass AK, Garimo I, Ramsan M, Ali A, Mårtensson A, Björkman A. 2015. Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis 211:1476–1483. doi:10.1093/infdis/jiu655.
    1. Mogeni P, Williams TN, Omedo I, Kimani D, Ngoi JM, Mwacharo J, Morter R, Nyundo C, Wambua J, Nyangweso G, Kapulu M, Fegan G, Bejon P. 2017. Detecting malaria hotspots: a comparison of rapid diagnostic test, microscopy, and polymerase chain reaction. J Infect Dis 216:1091–1098. doi:10.1093/infdis/jix321.
    1. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, Hamainza B, Moonga H, Kooma E, Chizema Kawesha E, Yukich J, Keating J, Porter T, Conner RO, Earle D, Steketee RW, Miller JM. 2016. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial. J Infect Dis 214:1831–1839. doi:10.1093/infdis/jiw416.
    1. van Eijk AM, Ramanathapuram L, Sutton PL, Kanagaraj D, Sri Lakshmi Priya G, Ravishankaran S, Asokan A, Tandel N, Patel A, Desai N, Singh R, Sullivan SA, Carlton JM, Srivastava HC, Eapen A. 2016. What is the value of reactive case detection in malaria control? A case-study in India and a systematic review. Malar J 15:67. doi:10.1186/s12936-016-1120-1.
    1. Imwong M, Hanchana S, Malleret B, Rénia L, Day NPJ, Dondorp A, Nosten F, Snounou G, White NJ. 2014. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol 52:3303–3309. doi:10.1128/JCM.01057-14.
    1. Britton S, Cheng Q, McCarthy JS. 2016. Novel molecular diagnostic tools for malaria elimination: a review of options from the point of view of high-throughput and applicability in resource limited settings. Malar J 15:88. doi:10.1186/s12936-016-1158-0.
    1. Das S, Jang IK, Barney B, Peck R, Rek JC, Arinaitwe E, Adrama H, Murphy M, Imwong M, Haohankhunnatham W, Ling CL, Proux S, Rist M, Seilie AM, Hanron A, Daza G, Chang M, Nakamura T, Kalnoky M, Labarre P, Murphy SC, McCarthy JS, Nosten F, Greenhouse B, Allauzen S, Domingo GJ. 2017. Performance of a high-sensitivity rapid diagnostic test for Plasmodium falciparum malaria in asymptomatic individuals from Uganda and Myanmar and naive human challenge infections. Am J Trop Med Hyg 97:1540–1550. doi:10.4269/ajtmh.17-0245.
    1. Das S, Peck RB, Barney R, Jang IK, Kahn M, Zhu M, Domingo GJ. 2018. Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples. Malar J 17:118. doi:10.1186/s12936-018-2268-7.
    1. Parker DM, Landier J, Thu AM, Lwin KM, Delmas G, Nosten FH, Malaria Elimination Task Force Group. 2017. Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar. Wellcome Open Res 2:98. doi:10.12688/wellcomeopenres.12741.2.
    1. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, the Malaria Elimination Task Force Group . 2018. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet 391:1916–1926. doi:10.1016/S0140-6736(18)30792-X.
    1. Sandeu MM, Bayibéki AN, Tchioffo MT, Abate L, Gimonneau G, Awono-Ambéné PH, Nsango SE, Diallo D, Berry A, Texier G, Morlais I. 2017. Do the venous blood samples replicate malaria parasite densities found in capillary blood? A field study performed in naturally-infected asymptomatic children in Cameroon. Malar J 16:345. doi:10.1186/s12936-017-1978-6.
    1. Marquart L, Butterworth A, McCarthy JS, Gatton ML. 2012. Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. Malar J 11:74. doi:10.1186/1475-2875-11-74.
    1. Mayxay M, Pukrittayakamee S, Chotivanich K, Looareesuwan S, White NJ. 2001. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans R Soc Trop Med Hyg 95:179–182.
    1. Cohen JM, Le Menach A, Pothin E, Eisele TP, Gething PW, Eckhoff PA, Moonen B, Schapira A, Smith DL. 2017. Mapping multiple components of malaria risk for improved targeting of elimination interventions. Malar J 16:459. doi:10.1186/s12936-017-2106-3.
    1. Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, Cunningham J. 2014. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J 13:283. doi:10.1186/1475-2875-13-283.
    1. Baker J, Ho M-F, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, Kyaw MP, Luchavez J, Membi C, Menard D, Murillo C, Nhem S, Ogutu B, Onyor P, Oyibo W, Wang SQ, McCarthy J, Cheng Q. 2010. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J 9:129. doi:10.1186/1475-2875-9-129.

Source: PubMed

3
Subscribe